Arrhythmias & electrophysiology
Outcomes of Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Closure: A Retrospective Single-Center Experience
Study context
- Population
- Patients undergoing concomitant atrial fibrillation (AF) ablation and left atrial appendage closure (LAAC), June 2015–August 2021
- Participants
- 178 patients
- Outcome
- Safety and efficacy: procedural success, periprocedural complications, thromboembolism, bleeding, arrhythmia recurrence
Methodological detailsconsecutive patients
- Consecutive patients
Main finding
As reported in the abstract
median follow-up 412 days (IQR 213 to 781)
- Pulmonary vein isolation achieved
- all patients
- LAAC aborted
- 15 cases
- LAAC success rate
- 91.6%
- Strokes
- 2
- TIAs
- 3
- Annual stroke/TIA risk at 1 year
- 1.7%
- Annual stroke/TIA risk at 2 years
- 4.6%
- Complete seal intraprocedurally
- 97.5%
- Complete seal on initial follow-up (no major leaks)
- 73.7%
- Anticoagulation discontinued
- 93.8%
Observational data: associations, not effects.
Safety
Periprocedural complications
- Periprocedural complications rate
- 6.2%
Device-related thrombus
- Device-related thrombus, resolved with anticoagulation
- 2 cases (1.3%)
Bleeding
- Bleeding events
- 34
- Patients with bleeding
- 28 (17.4%)
LAAC aborted
- LAAC aborted (success rate 91.6%)
- 15 cases
Original publication
Outcomes of Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Closure: A Retrospective Single-Center Experience. JACC Adv. Published 14 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →